Zhittya Genesis Medicine (zgm.care) pioneers innovative clinical trials for Parkinson’s Disease, Heart Disease, Type-2 Diabetes and more. Offering hope through cutting-edge regenerative …

LAS VEGAS, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that it is starting a “Compassionate Use Clinical Trial” for …

We are seeking to commercialize human FGF-1, a potent, naturally-occurring growth factor. Since its discovery in the 1970s, FGF-1 has been extensively studied. Since 1998, Daniel Montano, …

Since May 2022, Zhittya Genesis Medicine has dosed over 196 individuals suffering from Parkinson’s Disease in Medical Research Studies. Beyond demonstrating potentially …

In previous Phase II USA FDA clinical trials, Zhittya Genesis Medicine established that FGF-1 is a potent healer of diabetic foot ulcers, accelerating their healing, and, in one study, completely …

Latest updates and news from Zhittya Genesis Medicine, covering breakthrough research, medical innovations, and company announcements.

6 days ago · See the latest Zenta Group Co Ltd stock price (ZGM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

At Zhittya Genesis Medicine, precision and purity ar... the core of our work. One of the most critical steps in. our University of Nevada, Reno lab. level of safety and efficacy. Achieving this …

Webull offers ZENTA GROUP CO LTD (ZGM) historical stock prices, in-depth market analysis, NASDAQ: ZGM real-time stock quote data, in-depth charts.

LAS VEGAS, June 16, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that the human test subjects in its first-in-human research …